Landmark Depression Treatment Studies to be presented by CNS Response Inc. (CNSO.OB) at U.S. Psychiatric and Mental Health Congress
CNS Response Inc. has developed a data analysis capability that, when paired with a non-invasive EEG, analyzes a patient’s brain waves and compares those results to a patient outcome database, generating an rEEG report that allows psychiatrists to create personalized medication regimens for the patient. According to the company, depression costs U.S. employers $83 billion annually; more than half of these costs are associated with treatment-resistant depression. Individuals with treatment-resistant depression cost $8,500 more per year than patients with ordinary depression. Through various studies, rEEG is the first objective, physiology-based, personalized medical technologies proven to efficiently and consistently enable psychiatrists…